0.5398
Schlusskurs vom Vortag:
$0.5958
Offen:
$0.5793
24-Stunden-Volumen:
821.58K
Relative Volume:
0.05
Marktkapitalisierung:
$22.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-0.7326
EPS:
-0.7368
Netto-Cashflow:
-
1W Leistung:
-26.58%
1M Leistung:
+133.02%
6M Leistung:
-29.31%
1J Leistung:
-67.91%
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Firmenname
Calidi Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 794-9600
Adresse
4475 Executive Drive, Suite 200, San Diego
Vergleichen Sie CLDI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CLDI
Calidi Biotherapeutics Inc
|
0.5321 | 20.20M | 0 | -23.36M | 0 | -0.7368 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
460.08 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
562.13 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
388.30 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
661.28 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
293.06 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-11-22 | Eingeleitet | H.C. Wainwright | Buy |
2023-10-09 | Eingeleitet | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Batesville Daily Guard
What is Calidi Biotherapeutics Inc. company’s growth strategyStock Market Forecasts From AI Tools - jammulinksnews.com
Chart based analysis of Calidi Biotherapeutics Inc. trendsChart Driven High Reward Trading Setup Presented - metal.it
Live Scanner Shows Breakout on Calidi Biotherapeutics Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
Calidi Biotherapeutics Stock Plunges 10.6% Despite FDA Fast Track Designation - AInvest
Is it too late to sell Calidi Biotherapeutics Inc.AI Screener Based Stock Summary Report - Newser
What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Screener With Smart Filters - Newser
Candlestick signals on Calidi Biotherapeutics Inc. stock todayLong-Term Stock Growth Forecast Insights - Newser
Calidi Biotherapeutics Receives FDA Fast Track Designation - GlobeNewswire
Short Covering May Lift Calidi Biotherapeutics Inc. in Near TermShort Term High Yield Stock Tips for Active Traders - metal.it
Calidi Biotherapeutics Stock Soars 68% on FDA Fast Track Designation - AInvest
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma - The Manila Times
FDA grants fast track designation to Calidi’s CLD-201 for sarcoma - Investing.com Nigeria
FDA Fast-Tracks Revolutionary Stem Cell-Viral Therapy for Aggressive Cancer Treatment - Stock Titan
Is Calidi Biotherapeutics Inc. a Top Dividend Stock to Watch in 2025Early Entry Ideas with Momentum Potential - Newser
Calidi Biotherapeutics Inc. Stock Support and Resistance Levels You Should KnowValue Investing Checklist with Entry Signals - Newser
Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionMarket Ready Picks with Technical Support - Newser
Published on: 2025-07-29 02:14:07 - Newser
Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Optimize Market Dynamics - citybuzz -
Is Calidi Biotherapeutics Inc. stock overvalued or undervaluedPhenomenal wealth increase - jammulinksnews.com
How to forecast Calidi Biotherapeutics Inc. trends using time seriesPrice Action Summary and Entry Strategy Guide - Newser
How to interpret RSI for Calidi Biotherapeutics Inc. stockShort Term Opportunity Finder with Tools - Newser
Does Calidi Biotherapeutics Inc. stock perform well during market downturnsRecord-setting profit potential - jammulinksnews.com
Why Did Calidi Biotherapeutics Stock Plunge 10.55%? - AInvest
What are analysts’ price targets for Calidi Biotherapeutics Inc. in the next 12 monthsMaximize returns with strategic portfolio planning - jammulinksnews.com
How does Calidi Biotherapeutics Inc. compare to its industry peersInvest confidently with professional guidance - jammulinksnews.com
How volatile is Calidi Biotherapeutics Inc. stock compared to the marketHigh-yield market plays - jammulinksnews.com
What makes Calidi Biotherapeutics Inc. stock price move sharplyAccelerated wealth expansion - jammulinksnews.com
Buy Signal for Calidi Biotherapeutics Inc. Stock Key Technical Indicators to WatchSmart Trading With Safety Margin - Newser
Calidi announces reverse stock split, expected to begin trading on a 1-for-12 split adjusted basis - MSN
Calidi announces 1-for-12 reverse stock split - TipRanks
Calidi Biotherapeutics' 1-for-12 Reverse Stock Split: Strategic Rebranding or a Desperate Lifeline? - AInvest
Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Enhance Market Appeal - Quiver Quantitative
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025 - GlobeNewswire
Calidi Biotech Plans Major 1:12 Reverse Split: What Shareholders Must Know Before August 5 - Stock Titan
What analysts say about Calidi Biotherapeutics Inc. stockExplosive returns - PrintWeekIndia
Is Calidi Biotherapeutics Inc. a good long term investmentMassive portfolio appreciation - PrintWeekIndia
Is Calidi Biotherapeutics Inc. stock overhyped or has real potentialTriple-digit returns - jammulinksnews.com
What drives Calidi Biotherapeutics Inc. stock priceRapid wealth creation - PrintWeekIndia
Should I buy Calidi Biotherapeutics Inc. stock before earningsExplosive portfolio gains - jammulinksnews.com
Calidi Biotherapeutics Inc. Stock Analysis and ForecastMassive profits - PrintWeekIndia
Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):